Gastroenterology Recurrent C. difficile Infection: Expert Perspectives

Clinicians require up-to-date knowledge of evidence-based treatment of initial and recurrent CDI to reduce its burden and improve clinical outcomes.

CME: 0.5

Oncology Redefining Breast Cancer Treatment with Personalized Medicine

The target audience for this initiative includes oncologists, oncology APPs and nurses, and other healthcare professionals (HCPs) involved in managing patients with breast cancer..

CME: 3.0

This educational activity is designed for cardiologists, infectious disease specialists, primary care physicians, and other clinicians interested in the management of patients with HIV-related cardiovascular disease.

Asthma Personalized Medicine in Severe Asthma

The latest evidence-based treatments for severe asthma in addition to a review of established therapies that are essential in helping patients achieve optimal functional status and quality of life.

CME: 1.75

Oncology Immunology in Lung Cancer: Biomarker Relevance and Integration of Therapies

To address the educational needs of oncologists and multidisciplinary oncology care team practitioners in the treatment of lung cancer.

CME: 1.5

Oncology Challenges and Developments in Opioid-induced Constipation

This webcast will review the advantages and disadvantages of currently available treatment options for opioid-induced constipation (OIC)

CME: 0.75

Oncology Stem Cell Transplantation, Maintenance Therapy, and Relapsed/Refractory Disease

This activity presents a robust roundtable discussion in which our expert faculty provides insights on such issues as determining the optimal timing and approach for autologous stem cell transplantation (ASCT), considering new factors when weighing the benefits and risks of maintenance therapy, and choosing between the various therapeutic options in the relapsed/refractory setting. This activity includes downloadable resources (including supplemental figures and tables).

CME: 1.0

Psychiatric Medicine Comorbid Conditions and Antipsychotic Use in Patients with Depression

Major Depressive Disorder (MDD) is a debilitating condition that nearly 20% of the general population in the United States will experience at some point in their life. The ultimate goal of care providers is to move patients suffering from MDD to remission, then recovery, and to avoid a relapse. While this alone is a challenge for clinicians, it becomes even more difficult in patients with cardiovascular disease risk factors such as smoking, diabetes, hypertension, obesity and dyslipidemia. Further complicating matters are the risks associated with some medications used to treat depression.

CME: 0.5

Hematology/Oncology Multiple Myeloma Expert Roundtable: Risk Assessment, Minimal Residual Disease, and Precision Medicine

The expansion of clinical options brings both opportunities and challenges for health care providers who see myeloma patients.

CME: 0.5